Navigation Links
Mylan Declares Quarterly Preferred Stock Dividend
Date:10/30/2008

PITTSBURGH, Oct. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on Nov. 17, 2008, to holders of preferred stock of record as of Oct. 31, 2008.

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 2,453 women ages 18 to 68 found that lubricant us...ontributed to higher ratings of pleasurable and sa...een recommended to women to improve the comfort of...nal tearing, yet strikingly little available data ...iated vaginal symptoms. , The study, conducted ...
(Date:11/8/2009)...hen Medicare, improve coverage for all Americans ... SUMMARY: Yesterday the United States House of Re...egislation that would strengthen Medicare for seni...that prices millions of Americans out of affordabl...are for America Act (H.R. 3962) makes prescription...
(Date:11/8/2009)...s self-assurance, research finds , , SUN...ve been right when she told you to sit up straight...ke you feel more confident about your thoughts. ,...ht gives a good impression to other people," Richa...professor at Ohio State University, said in a univ...
(Date:11/8/2009)...l Nation,s Job Creators ,, WASHINGTON, Nov. 8 /...e passage of the health care bill (H.R. 3962), Sma...uncil) president & CEO Karen Kerrigan issued t...hose voting for H.R. 3962 voted to burden our nati...axes and penalties. Even in the best of economic t...
(Date:11/8/2009)... "Preventing and Healing AIDS Through Our Inn...t AIDS is a result of multiple, repeated and chron...m stressor agents, which can be either chemical, p... , Oakland, CA (PRWEB) Nov... biologists, physicians, chemists and other scient...
Breaking Medicine News(10 mins):Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Good Posture May Inspire Confidence 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
...s physicians keep up to date with the latest in Ca...in the detection of cardiovascular disease. CVCTA ...ng to cardiovascular imaging. Led by Medical Direc... 2008 -- CVCTA Education of San Francisco, the l...
...atisfaction with life? Then the pen may be a might... University,s Dr. Steven Toepfer. , Toepfer, an a...at university,s Salem Campus, says that expressive...rican dream. We are wealthier than previous genera...
...TM) Campaign Reaches $1 Million Dollar Donation Go...d Banks in Need , , NEW YORK, Nov. 25 Weight...e donation of one million dollars to two hunger fi...ight Watchers Online Subscribers during Lose For G...
...rtment of Energy,s (DOE) Brookhaven National Labor...B2 for the design of a "medical synchrotron" capab...on to cancerous tumors with minimal damage to surr...lity and benefits of this treatment for cancer pat...
...o-Assisted Thoracic Surgeon Dr. Robert J. Caccaval...nce, Dedication , , SOMERSET, N.J., Nov. 25 ...ay announced that one of its leading thoracic surg...Jersey Monthly,s annual list of "Top Doctors" t...
...ional, Inc. (Amex: BUF ) today announced that it...sthetics for the human market in the United States...ned subsidiary of RxElite Inc.(OTC Bulletin Board:...n overdue accounts owed to MINRAD International, I...
Other Medicine News:Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 2Health News:CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training 3Health News:Study: Want to be happier? Be more grateful 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4Health News:Physicists receive patent for improved cancer therapy device 2Health News:Physicists receive patent for improved cancer therapy device 3Health News:Renowned Thoracic Surgeon Recognized as 'Top Doctor' by Peers in Annual New Jersey Monthly Magazine Survey 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 2Health News:MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States 3
(Date:11/6/2009)...- Philips Respironics applauds the efforts of the ...o raise awareness about an important public health...elease of the first-ever government study to monit...a milestone in quantifying the size and scope of t...ry leader and sleep therapy manufacturer, Philips ...
(Date:11/6/2009)...-- Cyberonics, Inc. (Nasdaq: CYBX ) today announc...for the second quarter ended October 23, 2009 of i... November 18, 2009 at 5:00 PM EST. The company wi...lts on Thursday, November 19, 2009 at 9:00 AM EST....onference Call Instructions ,, To listen to t...
(Date:11/6/2009)...,, - Trial Will Compare NXL103 With Leading...esistant Staphylococcus Aureus (MRSA) Infections ,...pany focused on the discovery and,development of n...ant global,problem of microbial resistance, announ...l NXL103 (flopristin/linopristin), has started a P...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Skinovative 28R 29 Announces a Safe Non Surgical Liposuction Alternative With the Launch of Zerona 28TM 29 Laser 50923 1Skinovative 28R 29 Announces a Safe Non Surgical Liposuction Alternative With the Launch of Zerona 28TM 29 Laser 50923 2Skinovative 28R 29 Announces a Safe Non Surgical Liposuction Alternative With the Launch of Zerona 28TM 29 Laser 50923 3Tyco to Report Third Quarter Results July 30 2009 50918 1Burrill 26 Company Invests in Taiwan Liposome Company 12918 1Burrill 26 Company Invests in Taiwan Liposome Company 12918 2Burrill 26 Company Invests in Taiwan Liposome Company 12918 3
...ntegrated Biomarker and Imaging Study) Results Dem...rug Development, SAN DIEGO, Calif., Sept. 2 Volc...403], a leading manufacturer of,intravascular ultr...nology,announced today the use of its VH(R) IVUS (...2 trial (Integrated Biomarker and Imaging Study). ...
...ermany, Sept. 2 Data presented today,at the Annua...howed that,the investigational oral Factor Xa inhi...mboembolism (VTE) compared with dalteparin among p...ment surgery. There was a,statistically significan...,observed bleeding rates were low across the group...
Other Medicine Technology:Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 2Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 3Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib 4Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2
Rectangular Square Presentation Case
Essilor Laboratories of America
Abba optical
Distribution Center
Medicine Products: